Inflammasome Expression and Cytomegalovirus Viremia in Critically Ill Patients with Sepsis

Overview

Journal J Clin Virol

Specialty Microbiology

Date 2017 May 28

PMID 28550722

Citations 6

Authors

Nina Singh

Makoto Inoue

Ryosuke Osawa

Marilyn M Wagener

Mari L Shinohara

Affiliations

Soon will be listed here.

Abstract

Background: CMV viremia is a contributor to poor outcomes in critically ill patients with sepsis.

Objectives: To assess the expression levels of genes encoding inflammasome-related proteins in the development of CMV viremia in critically ill patients with sepsis.

Study Design: A cohort of CMV-seropositive critically ill patients with sepsis due to bloodstream infection underwent weekly testing for CMV viremia. Blood samples to evaluate mRNA levels of genes encoding CASP1, ASC, NLRP1, NLRP3, and NLRP12 were collected at the time of enrollment. Clinical outcomes were assessed at 30days or until death/discharge from ICU.

Results: CMV viremia was documented in 27.5% (8/29) of the patients, a median of 7days after the onset of bacteremia. Patients with sepsis who developed CMV viremia had higher CASP1 although this was not statistically significant (relative mean 3.6 vs 1.8, p=0.13). Development of high grade CMV viremia however, was significantly associated with CASP1; septic patients who developed high grade CMV viremia had significantly higher CASP1than all other patients (relative mean 5.5 vs 1.8, p=0.016).

Conclusions: These data document possible involvement of inflammasome in the pathogenesis of CMV. Regulating the host immune response by agents that target these genes may have implications for improving CMV-related outcomes in these patients.

Citing Articles

Active cytomegalovirus infection in mechanically ventilated patients with sepsis.

Zhang Z, Zhang J, Dai S, Fan X, Liu Y, Sun J BMC Infect Dis. 2024; 24(1):1405.

PMID: 39696007 PMC: 11654325. DOI: 10.1186/s12879-024-10304-4.

Mesenchymal Stem Cell-Derived Exosomes Attenuate Murine Cytomegalovirus-Infected Pneumonia via NF-κB/NLRP3 Signaling Pathway.

Chen F, Chen Z, Wu H, Chen X, Zhan P, Wei Z Viruses. 2024; 16(4).

PMID: 38675960 PMC: 11054941. DOI: 10.3390/v16040619.

Secreted osteopontin from CD4 T cells limits acute graft-versus-host disease.

Aggarwal N, Deerhake M, DiPalma D, Shahi S, Gaggioli M, Mangalam A Cell Rep. 2021; 37(13):110170.

PMID: 34965439 PMC: 8759344. DOI: 10.1016/j.celrep.2021.110170.

Impact of cytomegalovirus load on host response to sepsis.

Marandu T, Dombek M, Cook C Med Microbiol Immunol. 2019; 208(3-4):295-303.

PMID: 30976913 DOI: 10.1007/s00430-019-00603-y.

Neutrophil pyroptosis: new perspectives on sepsis.

Liu L, Sun B Cell Mol Life Sci. 2019; 76(11):2031-2042.

PMID: 30877336 PMC: 11105444. DOI: 10.1007/s00018-019-03060-1.

References

Frantzeskaki F, Karampi E, Kottaridi C, Alepaki M, Routsi C, Tzanela M . Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers. J Crit Care. 2014; 30(2):276-81. DOI: 10.1016/j.jcrc.2014.10.002. View

Arend W, Palmer G, Gabay C . IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev. 2008; 223:20-38. DOI: 10.1111/j.1600-065X.2008.00624.x. View

Dupaul-Chicoine J, Arabzadeh A, Dagenais M, Douglas T, Champagne C, Morizot A . The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity. Immunity. 2015; 43(4):751-63. DOI: 10.1016/j.immuni.2015.08.013. View

Cook C, Trgovcich J, Zimmerman P, Zhang Y, Sedmak D . Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice. J Virol. 2006; 80(18):9151-8. PMC: 1563908. DOI: 10.1128/JVI.00216-06. View

Sutterwala F, Ogura Y, Flavell R . The inflammasome in pathogen recognition and inflammation. J Leukoc Biol. 2007; 82(2):259-64. DOI: 10.1189/jlb.1206755. View

Mariathasan S, Monack D . Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol. 2006; 7(1):31-40. DOI: 10.1038/nri1997. View

Brochner A, Toft P . Pathophysiology of the systemic inflammatory response after major accidental trauma. Scand J Trauma Resusc Emerg Med. 2009; 17:43. PMC: 2757019. DOI: 10.1186/1757-7241-17-43. View

Allen I, Tekippe E, Woodford R, Uronis J, Holl E, Rogers A . The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med. 2010; 207(5):1045-56. PMC: 2867287. DOI: 10.1084/jem.20100050. View

Hummel M, Abecassis M . A model for reactivation of CMV from latency. J Clin Virol. 2002; 25 Suppl 2:S123-36. DOI: 10.1016/s1386-6532(02)00088-4. View

10.

Inoue M, Chen P, Siecinski S, Li Q, Liu C, Steinman L . An interferon-β-resistant and NLRP3 inflammasome-independent subtype of EAE with neuronal damage. Nat Neurosci. 2016; 19(12):1599-1609. PMC: 5482232. DOI: 10.1038/nn.4421. View

11.

Lamkanfi M, Kanneganti T, Franchi L, Nunez G . Caspase-1 inflammasomes in infection and inflammation. J Leukoc Biol. 2007; 82(2):220-5. DOI: 10.1189/jlb.1206756. View

12.

Ellebedy A, Lupfer C, Ghoneim H, DeBeauchamp J, Kanneganti T, Webby R . Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59. Proc Natl Acad Sci U S A. 2011; 108(7):2927-32. PMC: 3041074. DOI: 10.1073/pnas.1012455108. View

13.

Staras S, Dollard S, Radford K, Flanders W, Pass R, Cannon M . Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis. 2006; 43(9):1143-51. DOI: 10.1086/508173. View

14.

Hu B, Elinav E, Flavell R . Inflammasome-mediated suppression of inflammation-induced colorectal cancer progression is mediated by direct regulation of epithelial cell proliferation. Cell Cycle. 2011; 10(12):1936-9. DOI: 10.4161/cc.10.12.16008. View

15.

Loser P, Jennings G, Strauss M, Sandig V . Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB. J Virol. 1998; 72(1):180-90. PMC: 109363. DOI: 10.1128/JVI.72.1.180-190.1998. View

16.

Kanayama M, Inoue M, Danzaki K, Hammer G, He Y, Shinohara M . Autophagy enhances NFκB activity in specific tissue macrophages by sequestering A20 to boost antifungal immunity. Nat Commun. 2015; 6:5779. PMC: 4304414. DOI: 10.1038/ncomms6779. View

17.

Osawa R, Wagener M, Singh N . Cytomegalovirus infection in patients with sepsis due to bloodstream infections: lower risk and better outcomes in new versus already hospitalised intensive care unit admissions. Anaesth Intensive Care. 2016; 44(5):571-80. DOI: 10.1177/0310057X1604400514. View

18.

Jira M, Polacek V, Strejcek J, Fara M, Konigova R . Natural killer cell activity following thermal injury. Scand J Plast Reconstr Surg Hand Surg. 1988; 22(2):131-3. DOI: 10.3109/02844318809072384. View

19.

Roy S, Arav-Boger R . New cell-signaling pathways for controlling cytomegalovirus replication. Am J Transplant. 2014; 14(6):1249-58. PMC: 4280670. DOI: 10.1111/ajt.12725. View

20.

Sambucetti L, Cherrington J, Wilkinson G, Mocarski E . NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 1989; 8(13):4251-8. PMC: 401626. DOI: 10.1002/j.1460-2075.1989.tb08610.x. View